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ABSTRACT 
 
Background: Infection with Helicobacter pylori (HP) estimated to occur in 50% of 
the population in the world. Helicobacter pylori infection causes inflammation of the 
gastric mucosa and gastric epithelial release of interleukin-1β, interleukin-6, 
interleukin-8 and tumor necrosis factor α. Interleukin-8 plays a role in the degree of 
chronic inflammation of the gastric mucosa and gastric cancer risk. There has been 
no research on differences in the expression of interleukin-8 is based on chronic and 
chronic active inflammation on biopsy of the gastric mucosa with Helicobacter pylori 
infection in Hospital Dr. Sardjito. 
Objective: To prove the differences in the expression of interleukin-8 of chronic 
inflammation and gastric mucosal biopsy active chronic infection with Helicobacter 
pylori. 
Methods: This study used a cross-sectional design. Examined the expression of 
interleukin-8 on the rest of the biopsy sample HP (+) in August 2009 to March 2014. 
Classification of chronic inflammatory and chronic active obtained through 
histopathology report. Categorical numerical data from the two groups, unpaired, the 
distribution is not normal: Mann-Whitney test. Differences were considered 
significant if it was obtained p <0.05 with a confidence interval of 95%. 
Results: There were 41 samples of gastric mucosa biopsy preparations, comprising 9 
samples of chronic inflammation and 32 samples of chronic inflammatory active of 
the gastric mucosa. The median value of the expression of IL-8 eptitel surface on 
chronic inflammation by 83 (40-94)% and the active chronic inflammation by 82 (19-
94). Comparison test with Mann Whitney U test. From the statistical calculations p 
value = 0.887  with p> 0.05 
Conclusion: There is no difference in the expression of interleukin-8 in 
inflammatory chronic active and chronic inflammation of the gastric mucosa with 
Helicobacter pylori infection. 
Keywords: Helicobacter pylori, interleukin-8, chronic inflammation and chronic 
inflammatory active. 
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Abstrak 
Latar belakang: Infeksi Helicobacter pylori (HP) diperkirakan terjadi pada 50% populasi di 
dunia. Infeksi Helicobacter pylori menyebabkan inflamasi mukosa lambung dan epitel lambung 
melepaskan interleukin-1β, interleukin-6, interleukin-8, dan tumor necrosis factor α. Interleukin-8 
berperan dalam derajat inflamasi kronik mukosa lambung dan risiko terjadinya kanker lambung. 
Belum ada penelitian tentang perbedaan ekspresi interleukin-8 berdasarkan pada inflamasi kronik 
dan kronik aktif pada biopsi mukosa lambung  dengan infeksi Helicobacter pylori di RSUP Dr. 
Sardjito 
Tujuan Penelitian: Untuk membuktikan adanya perbedaan ekspresi interleukin-8 pada 
inflamasi kronik dan kronik aktif biopsi mukosa lambung dengan infeksi Helicobacter pylori. 
Metode:  Penelitian ini menggunakan desain potong lintang. Dilakukan pemeriksaan ekspresi 
interleukin-8 pada sisa sampel biopsi HP (+) bulan Agustus 2009 sampai Maret 2014. 
Klasifikasi inflamasi kronik dan kronik aktif diperoleh melalui laporan  histopatologi. Data 
numerik-kategorik  dari  2 kelompok, tidak berpasangan, distribusi tidak normal: uji Mann-
Whitney U. Perbedaan dianggap bermakna jika didapatkan p< 0,05 dengan interval kepercayaan 
95% 
Hasil:  Didapatkan 41 sampel   preparat biopsi mukosa lambung, terdiri 9  sampel inflamasi 
kronik  dan 32 sampel inflamasi kronik aktif mukosa  lambung. Nilai median ekspresi IL-8 
eptitel permukaan pada inflamasi kronik sebesar 83 (40-94)% dan pada inflamasi kronik aktif 
sebesar 82 (19-94). Dilakukan uji komparasi dengan uji Mann Whitney U. Dari perhitungan 
statistik didapatkan nilai p=0,887 dengan p>0,05. 
Simpulan:  Tidak terdapat perbedaan ekspresi interleukin-8 pada inflamasi kronik dan 
inflamasi kronik aktif mukosa lambung dengan infeksi helicobacter  pylori. 
Kata Kunci:  Helicobacter pylori, interleukin-8, inflamasi kronik dan inflamasi  kronik aktif. 
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Background  
Infection with Helicobacter 
pylori (H. pylori) estimated to occur in 
50% of the population in the world. 
H. pylori infection is more common in 
developing countries amounting to 70-
90% and only 40-50% in industrialized 
countries (Kuster, 2006). Research in 
Yogyakarta, the prevalence of H. 
pylori infection in patients with 
chronic dyspepsia who underwent 
endoscopy at Hospital Dr. Sardjito is 
15.6%1. 
Helicobacter pylori infection 
causes inflammation of the gastric 
mucosa. Helicobacter pylori cause a 
persistent infection in most infected 
individuals. Acute inflammation is 
characterized by infiltration of 
neutrophils into the surface epithelium 
and lamina propria last from 1 to 4 
weeks and gradually replaced by a 
chronic mononuclear infiltrates in the 
lamina propria (chronic inflammation). 
Chronic Inflammation by 
Helicobacter pylori infection is the 
main cause of infection-related cancer, 
Helicobacter pylori so-called type I 
carcinogen (definite) since 1994 by 
WHO. The risk of gastric cancer 
incidence in Helicobacter pylori 
infection in developed countries by 1-
2%, and in developing countries by 
60-80%2,3,4. 
During inflammation occurs 
recruitment of neutrophils followed by 
T and B-lymphocytes, plasma cells, 
and macrophages in the infected 
epithelial gastric mucosa. Gastric 
epithelial release of interleukin-1β, 
interleukin-6, interleukin-8 and tumor 
necrosis factor α. Interleukin-8 is the 
most important neutrophil-activating 
chemokine expressed in gastric 
epithelial cells, as interleukin-8 is able 
to recruit lymphocytes and 
neutrophils. Furthermore, neutrophils 
release toxic metabolites, lysosome 
enzymes, reactive oxygen species 
(ROS) and reactive nitrogen species 
(RNS) thus creating the gastric 
mucosal epithelial damage5,6,7. 
Several studies have 
demonstrated an association of IL-8 
levels of gastric mucosa, gastric 
mucosal inflammation degree and risk 
of gastric cancer. Yamaoka research 
indicates more severe degrees of 
severity in H pylori positive than 
negative. Polimorfonulear (PMN) and 
mononuclear (MN) cell infiltration are 
more severe in the CagA positive 
strains. CagA positive strongly 
associated with high levels of IL-8 
gastric mucosa8. Research Bakir, 2008, 
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found the expression of interleukin-8 
increased by severity infiltration 
netrofit, lymphocytes and atropi9. 
Research Oh, 2002, the expression of 
interleukin-8 on duodenal gastric 
metaplasia associated with the degree 
of inflammation and Helicobacter 
pylori colony density10. 
Given the role of interleukin-8 
in the degree of chronic inflammation 
of the gastric mucosa and gastric 
cancer risk, researchers want to know 
about the differences in the expression 
of interleukin-8 based on chronic and 
chronic active inflammation in gastric 
mucosa biopsy on Indonesian people 
with Helicobacter pylori infection. 
The purpose of this study was 
to prove the existence of differences 
in the expression of interleukin-8 in 
chronic inflammation and gastric 
mucosal biopsy active chronic 
infection with Helicobacter pylori. 
Research methods 
The study design was cross-
sectional (cross-sectional). The study 
conducted in the laboratory of the 
department of Pathology Dr. Sardjito 
from January 2014 until January 2015. 
The study used endoscopic biopsy 
samples of patients with dyspepsia, 
which have Helicobacter pylori 
infection in August 2009 to March 
2014. 
Inclusion criteria for the study: 
preparation endoscopy with biopsy of 
anatomical pathology examination 
obtained active chronic inflammation 
and chronic infection with 
Helicobacter pylori, a biopsy sample 
taken from a minimum of 1 antrum 
and 1 corpus gastric mucosa, and 
worthy of biopsy samples for 
examination interleukin-8. Exclusion 
criteria: biopsy samples taken does not 
qualify the examination and the data 
readout no anatomic pathology 
biopsy. The independent variable in 
this study is the expression of IL-8, 
and the dependent variable is the 
histopathological inflammation of the 
gastric mucosa. 
Endoscopic biopsy samples 
infected with chronic inflammatory 
Helicobacter pylori that meet the 
inclusion and exclusion criteria 
examined interleukin-8 using the 
monoclonal antibody technique. The 
readings of the expression of 
interleukin-8 carried by one-person 
pathologist were from the laboratory 
Anatomical Pathology Dr. Sardjito. 
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The following lines of inquiry 
 
   
       
              
 
     
       
 
 
 
 
  
 
Biopsy samples obtained by 
endoscopic examination in building 
integrated central surgical department 
of Dr. Sardjito. Helicobacter pylori-
positive status is discovered bacteria 
H. pylori in the gastric mucosa biopsy, 
chronic inflammation is found 
mononuclear cells (lymphocytes) and 
plasma in gastric mucosa biopsy, 
chronic active inflammation was 
found lymphocytes, plasma and 
polymorphonuclear (neutrophils) in 
biopsy of the gastric mucosa, the 
expression of interleukin-8 is a vast 
proportion of the superficial 
epithelium that express interleukin-8 
per total superficial epithelial. 
Sample readings performed 3 
times by an observer (intra-observer 
agreement) then performed the 
reliability test using Cronbach Alpha. 
In this study showed Cronbach Alpha 
= 0962 which means that the readings 
Chronic inflammation 
Painting IL-8 Antibodies 
Inclusion criteria Exclusion criteria 
Data analysis 
Active Chronic 
Inflammation 
Gastric Mucosal biopsy samples 
with Helicobacter pylori (+) 
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are consistent and proper to be used for research. 
 
 
Results and Discussion 
Table 1. Characteristics of Basic Research Subjects 
 
 Variable n (%) Mean ± SD 
Age (years)  50,58 ±14,42 
 
Gender 
         Man 
Woman 
 
26 (63,4) 
15 (36,6) 
 
histopathologic features 
         Chronic inflammation 
Active chronic Inlamation 
 
9 (22,0) 
32 (78,0) 
 
 
Histopathology features of 
active chronic inflammation mild  
(PMN +) 
Moderate (PMN ++) 
 
 
26 (63,4) 
6 (36,6) 
 
 
 
chronic inflammation  
Man 
Woman 
 
7(77.8) 
2(22,2) 
 
Active chronic inflammation 
Man 
Woman 
 
19(59,4) 
13(40,6) 
 
 
Subjects in this study were 41 
biopsy samples from patients 
undergoing gastroduodenal endoscopy 
with chronic dyspepsia diagnosis of 
Helicobacter infection pylori from 
August 2009 - March 2014. The basic 
characteristics of research subjects is 
shown in Table 1. The mean age in 
this study was 50.58 ± 14 , 42 years 
with the oldest 82 years of age and the 
youngest 26 years old. Samples from 
patients with male sex as much as 26 
samples (63.4%) and female gender 15 
samples (36.6%). Histopathologic 
features of gastric biopsy with chronic 
inflammation as much as 9 samples 
(22%) were found in men as much as 
7 samples (77.8%) and women 2 
samples (22.2%), and active chronic 
inflammation as much as 32 samples 
(78%) were obtained in men as much 
as 19 samples (59.4%) and 13 women 
(40.6%). 
Expression of interleukin-8 in 
the gastric mucosa of chronic 
inflammation in this study, the median 
of 0.83 (0.40 to 0.94)% and active 
chronic inflammation median of 0.82 
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(0.19 to 0.94)% (Table 2). Do Mann-
Whitney U test and the results 
obtained p = 0887 (p> 0.05). The 
results obtained showed no significant 
difference between the expression of 
interleukin-8 group of chronic 
inflammatory and chronic active 
inflammation of the gastric mucosa 
with Helicobacter pylori infection. 
 
Table 2. Expression of Interleukin-8 Based on histopathological Gastric Mucosal 
Inflammation (n = 41) 
 
Category n  Expression of IL-8 
(%) 
Median (min-max) 
 (p-value) 
 
chronic inflammation  
 
9 
 
0,83 (0,40-0,94) 
 
0,887* 
Active chronic 
inflammation 
32 0,82 (0,19-0,94)  
*Mann-Whitney U test 
 
The study also compared the 
expression of interleukin-8 in active 
chronic inflammation of the gastric 
mucosa by the degree of infiltration of 
PMN cells (Table 3). Interleukin-8 
expression in gastric mucosa without 
infiltration of PMN obtained a median 
of 0.83 (0.40 to 0.94) %, with mild 
infiltration (PMN +) obtained a 
median 82 (19-94) % and the 
infiltration medium (PMN ++) 
obtained a mean 62 ± 2.7%. Kruskal-
Wallis test showed no significant 
difference between the expression of 
interleukin-8 group without PMN 
infiltration, infiltration and infiltration 
were mild gastric mucosa with 
Helicobacter pylori infection (p = 
0.345). Results in this study that there 
was no difference in the expression of 
interleukin-8 in inflammatory chronic 
active and chronic inflammation, and 
there is no significant difference in the 
expression of interleukin-8 on gastric 
mucosal inflammation without PMN 
infiltration, chronic inflammation of 
mild and moderate active gastric 
mucosa with Helicobacter infection 
pylori.
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Table 3. Expression of Interleukin-8 Based on the degree of infiltration of PMN  
PMN infiltration degrees N  Expression of IL-8 
(%) 
[median (min-max) 
/ mean (SD)] 
 (p-value) 
Without PMN 9 0,83 (0,40-0,94) 0,345* 
Mild (PMN +) 26 0,82 (0,19-0,94) 
Moderate  (PMN ++) 6 0,62 ± 2,7 
*Kruskal-Wallis test 
 
These results differ from 
previous research studies that states 
there is a relationship between the 
expression of interleukin 8 with the 
degree of inflammation of the gastric 
mucosa8,9,10,11. Some things that affect 
differences in the expression of 
interleukin-8 results in this study with 
the results of previous research cannot 
be conducted due to the exclusion of 
confounding factors such as: Host 
with IL-8-251 genotype A / A and IL-
8-251 A / T express interleukin-8 is 
higher than the genotype IL-8-251 T / 
T, virulence factors of Helicobacter 
pylor positive Vaca express 
interleukin-8 on the corpus higher 
than Vaca negative and positive 
Helicobacter pylori CagA expressing 
interleukin-8 in the antrum five times 
higher than CagA negative, 
Helicobacter pylori colony density is 
closely linked with the expression of 
interleukin-8, smoking increases the 
expression of interleukin-8, the use of 
drugs known as proton pump 
inhibitors (PPI), the use of non-
steroidal anti-inflammatory drugs 
(NSAIDs), alcohol consumption, extra 
gastroduodenal diseases affecting the 
expression of IL-88,12,13,14,15. 
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Tabel 4. Expression of Interleukin-8 Based Sex 
Category N Expression of IL-8 (%) 
[median (min-max) 
/ mean (SD)] 
 (p-value) 
Man 26 0.83 (0.19-0.94) 0.139* 
Woman 14 0.67±0.24 
* Mann-Whitney U test 
 
Interleukin-8 expression by the 
epithelial cells of the gastric mucosa in 
men in this study, the median of 0.83 
(from 0.19 to 0.94)% and in women 
mean of 0.67 ± 0.24 (Table 4). To 
know is there any difference between 
the expression of interleukin-8 group 
of men and women then tested the 
Mann-Whitney U (distibusi abnormal 
data) and the results obtained p = 
0139 (p> 0.05). The results obtained 
showed no significant difference 
interleukin-8 expression of the gastric 
mucosa with Helicobacter pylori 
infection between men and women. 
These results are in contrast to 
studies conducted by Moshkowitz et al 
(2012) also demonstrated the 
expression of interleukin 8 in men is 
greater in women16. Kato 2004 study, 
the expression of interleukin-8 in men 
with chronic gastritis greater than 
premenopausal women. While the 
expression of interleukin-8 between 
men and postmenopausal women not 
different17. This is presumably due to 
hormonal differences between men 
and women. Women have the 
hormones estrogen and progesterone 
are able to maintain the stability of the 
gastric mucosa, so chronicity occurs 
less frequently in women. In this study 
does not distinguish whether the 
sample derived from postmenopausal 
women or not, so that the different 
results of this study with other studies 
could not be known whether due to 
hormonal differences. Differences 
may also occur because not done 
confounding factors such as genotype 
host, the virulence of Helicobacter 
pylori, Helicobacter pylori colony 
density, smoking, drinking alcoholic 
beverages, use of PPI medications, 
OAINs and comorbid disease patients 
 
Conclusions and Suggestions 
There were no differences in 
the expression of interleukin-8 in 
inflammatory chronic active and 
chronic inflammation of the gastric 
mucosa biopsy with Helicobacter 
Acta Interna The Journal of Internal Medicine, Volume 7 No.1, June 2017: page 18-28 
 
27 
 
pylori infection. For further research is 
necessary to control for confounding 
factors such as genotype host, the 
virulence of Helicobacter pylori, 
Helicobacter pylori colony density, 
smoking habits and use of PPI 
medications and NSAIDs and 
comorbid disease patients. 
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